A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3

Saint Vincent's Med Ctr, New York

Albany Med College / Clinical Pharmacy Studies, Albany

Georgetown Univ Med Ctr, Washington D.C.

Institute for Clinical Research, Washington D.C.

Carolinas Med Ctr, Charlotte

Univ of South Florida, St. Petersburg

Univ of Alabama at Birmingham, Birmingham

Vanderbilt Univ Med Ctr, Nashville

Wayne State Univ / Univ Health Ctr, Detroit

Univ of Wisconsin, Madison

Chicago Ctr for Clinical Research, Chicago

Northwestern Univ Med Ctr, Chicago

Tulane Univ / Tulane / LSU Clinical Trials Unit, New Orleans

Dallas VA Med Ctr, Dallas

Houston Clinical Research Network, Houston

Univ of Texas, Galveston

Univ of Utah School of Medicine, Salt Lake City

Harbor UCLA Med Ctr, Torrance

Kraus Med Partners, Los Angeles

Pacific Oaks Research, Sherman Oaks

San Francisco Gen Hosp, San Francisco

San Mateo County Med Ctr / San Mateo County AIDS Prog, San Mateo

East Bay AIDS Ctr, Berkeley

The Research and Education Group, Portland

AIDS Research Consortium of Atlanta, Atlanta

Santa Clara Valley Med Ctr, San Jose

Harvard Univ / Massachusetts Gen Hosp, Boston